The DOI matches its Crossref record; 127 of the 127 references it cites were found in a registry or an index.
Dysregulation and restoration of translational homeostasis in fragile X syndrome
Open accessAbstract
Fragile X syndrome (FXS), the most-frequently inherited form of intellectual disability and the most-prevalent single-gene cause of autism, results from a lack of fragile X mental retardation protein (FMRP), an RNA-binding protein that acts, in most cases, to repress translation. Multiple pharmacological and genetic manipulations that target receptors, scaffolding proteins, kinases and translational control proteins can rescue neuronal morphology, synaptic function and behavioural phenotypes in FXS model mice, presumably by reducing excessive neuronal translation to normal levels. Such rescue strategies might also be explored in the future to identify the mRNAs that are critical for FXS pathophysiology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“S6K1 has been shown to act downstream of TORC1 to drive EIF4E-regulated initiation of translation (Richter et al., 2015), and dampens translation of FMRP-regulated mRNAs by phosphorylating FMRP (Santoro et al., 2012).”
From Unifying Views of Autism Spectrum Disorders: A Consideration of Autoregulatory Feedback Loops (2016) · cites this paper as Richter et al., 2015
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
John, B., Enright, A. J., Aravin, A., Tuschl, T., Sander, C., & Marks, D. S. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020363 · Cited by 3,796
Regulation of mRNA Translation and Stability by microRNAs
Fabian, M. R., Sonenberg, N., & Filipowicz, W. (2010) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060308-103103 · Cited by 3,214
FMRP Stalls Ribosomal Translocation on mRNAs Linked to Synaptic Function and Autism
Darnell, J. C., Van Driesche, S. J., Zhang, C., Hung, K. Y. S., Mele, A., Fraser, C. E., Stone, E. F., Chen, C., Fak, J. J., Chi, S. W., et al. (2011) · Cell · doi:10.1016/j.cell.2011.06.013 · Cited by 2,072
Self-citationThe mGluR theory of fragile X mental retardation
Bear, M. F., Huber, K. M., & Warren, S. T. (2004) · Trends in Neurosciences · doi:10.1016/j.tins.2004.04.009 · Cited by 1,580
Regulation of translation initiation by FRAP/mTOR
Gingras, A.-C., Raught, B., & Sonenberg, N. (2001) · Genes & Development · doi:10.1101/gad.887201 · Cited by 1,545
HITS-CLIP yields genome-wide insights into brain alternative RNA processing
Licatalosi, D. D., Mele, A., Fak, J. J., Ule, J., Kayikci, M., Chi, S. W., Clark, T. A., Schweitzer, A. C., Blume, J. E., Wang, X., et al. (2008) · Nature · doi:10.1038/nature07488 · Cited by 1,352 · cited 2×
“…covalent crosslinking between proteins and the mRNAs to which they are bound followed by RNP immunoprecipitation and high-throughput sequencing 64,65 — it was shown that FMRP binds most frequently to the coding regions of mRNAs, with fewer binding sites within the 5 ′ and 3 ′ UTRs (the sites…”
BackgroundMethodmTOR signaling: At the crossroads of plasticity, memory and disease
Hoeffer, C. A., & Klann, E. (2010) · Trends in Neurosciences · doi:10.1016/j.tins.2009.11.003 · Cited by 1,128
Self-citationCLIP Identifies Nova-Regulated RNA Networks in the Brain
Ule, J., Jensen, K. B., Ruggiu, M., Mele, A., Ule, A., & Darnell, R. B. (2003) · Science · doi:10.1126/science.1090095 · Cited by 1,120
Brown, V., Jin, P., Ceman, S., Darnell, J. C., O'Donnell, W. T., Tenenbaum, S. A., Jin, X., Feng, Y., Wilkinson, K. D., Keene, J. D., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00568-2 · Cited by 1,109
Correction of Fragile X Syndrome in Mice
Dölen, G., Osterweil, E., Rao, B. S. S., Smith, G. B., Auerbach, B. D., Chattarji, S., & Bear, M. F. (2007) · Neuron · doi:10.1016/j.neuron.2007.12.001 · Cited by 979
Flagged first, then by citations
Cited by
Sorted by citations
Hagerman, R. J., Berry-Kravis, E., Hazlett, H. C., Bailey, D. B., Moine, H., Kooy, R. F., Tassone, F., Gantois, I., Sonenberg, N., Mandel, J. L., et al. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.65 · Cited by 838
Local translation in neurons: visualization and function
Holt, C., Martin, K. C., & Schuman, E. (2019) · Nature Structural & Molecular Biology · doi:10.1038/s41594-019-0263-5 · Cited by 463
Excitation/Inhibition Imbalance in Animal Models of Autism Spectrum Disorders
Lee, E., Lee, J., & Kim, E. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.05.011 · Cited by 468
Local protein synthesis is a ubiquitous feature of neuronal pre- and postsynaptic compartments
Hafner, A.-S., Donlin-Asp, P. G., Leitch, B., Herzog, E., & Schuman, E. M. (2019) · Science · doi:10.1126/science.aau3644 · Cited by 431
The molecular biology of FMRP: new insights into fragile X syndrome
Richter, J. D., & Zhao, X. (2021) · Nature Reviews Neuroscience · doi:10.1038/s41583-021-00432-0 · Cited by 390
Self-citationPSD95: A synaptic protein implicated in schizophrenia or autism?
Coley, A. A., & Gao, W. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.11.016 · Cited by 361
Signaling Pathways Involved in the Regulation of mRNA Translation
Roux, P. P., & Topisirović, I. (2018) · Molecular and Cellular Biology · doi:10.1128/mcb.00070-18 · Cited by 332
A synaptic perspective of fragile X syndrome and autism spectrum Disorders.
Bagni, C., & Zukin, R. S. (2019) · Neuron · doi:10.1016/j.neuron.2019.02.041 · Cited by 326
FMRP modulates neural differentiation through m6A-dependent mRNA nuclear export.
Edens, B. M., Vissers, C., Su, J., Arumugam, S., Xu, Z., Shi, H., Miller, N., Rojas Ringeling, F., Ming, G.-L., He, C., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.06.072 · Cited by 297
Fragile X mental retardation protein modulates the stability of its m6A-marked messenger RNA targets
Zhang, F., Kang, Y., Wang, M., Li, Y., Xu, T., Yang, W., Song, H., Wu, H., Shu, Q., & Jin, P. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy292 · Cited by 232
Lombardo, M. V., Moon, H. M., Su, J., Palmer, T. D., Courchesne, E., & Pramparo, T. (2018) · Molecular Psychiatry · doi:10.1038/mp.2017.15 · Cited by 201
Post-transcriptional regulation of gene expression and human disease
Corbett, A. H. (2018) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2018.02.011 · Cited by 202
Unifying Views of Autism Spectrum Disorders: A Consideration of Autoregulatory Feedback Loops
Mullins, C., Fishell, G., & Tsien, R. W. (2016) · Neuron · doi:10.1016/j.neuron.2016.02.017 · Cited by 167
Mechanisms of homeostatic plasticity in the excitatory synapse
Fernandes, D., & Carvalho, A. L. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13687 · Cited by 179
Kang, Y., Zhou, Y., Li, Y., Han, Y., Xu, J., Niu, W., Li, Z., Liu, S., Feng, H., Huang, W., et al. (2021) · Nature Neuroscience · doi:10.1038/s41593-021-00913-6 · Cited by 168
Self-citationThe m6A‐epitranscriptomic signature in neurobiology: from neurodevelopment to brain plasticity
Widagdo, J., & Anggono, V. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14481 · Cited by 157
Neurobiology of rapid-acting antidepressants: convergent effects on GluA1-synaptic function
Duman, R. S., Shinohara, R., Fogaça, M. V., & Hare, B. D. (2019) · Molecular Psychiatry · doi:10.1038/s41380-019-0400-x · Cited by 157
Rescue of oxytocin response and social behaviour in a mouse model of autism
Hörnberg, H., Pérez-Garci, E., Schreiner, D., Hatstatt-Burklé, L., Magara, F., Baudouin, S., Matter, A., Nacro, K., Pecho-Vrieseling, E., & Scheiffele, P. (2020) · Nature · doi:10.1038/s41586-020-2563-7 · Cited by 154
RNA G-quadruplexes and their potential regulatory roles in translation
Song, J., Perreault, J., Topisirović, I., & Richard, S. (2016) · Translation · doi:10.1080/21690731.2016.1244031 · Cited by 157
Activation of autophagy rescues synaptic and cognitive deficits in fragile X mice
Yan, J., Porch, M. W., Court-Vazquez, B. L., Bennett, M. V. L., & Zukin, R. S. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1808247115 · Cited by 146
Fragile X syndrome and associated disorders: Clinical aspects and pathology
Salcedo‐Arellano, M. J., Dufour, B. D., McLennan, Y. A., Martínez‐Cerdeño, V., & Hagerman, R. J. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104740 · Cited by 141
Disruption of mTOR and MAPK pathways correlates with severity in idiopathic autism
Rosina, E., Battan, B., Siracusano, M., Criscio, L. D., Hollis, F., Pacini, L., Curatolo, P., & Bagni, C. (2019) · Translational Psychiatry · doi:10.1038/s41398-018-0335-z · Cited by 129
RNA-binding proteins in neurological development and disease
Prashad, S., & Gopal, P. P. (2020) · RNA Biology · doi:10.1080/15476286.2020.1809186 · Cited by 124
The role of TGF-β superfamily signaling in neurological disorders
Kashima, R., & Hata, A. (2017) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmx124 · Cited by 130
Gonatopoulos-Pournatzis, T., Niibori, R., Salter, E. W., Weatheritt, R. J., Tsang, B., Farhangmehr, S., Liang, X., Braunschweig, U., Roth, J. F., Zhang, S., et al. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.01.006 · Cited by 120
Kim, C., Kang, D., Lee, E. K., & Lee, J. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/2062384 · Cited by 117
RNA-binding proteins balance brain function in health and disease
Schieweck, R., Ninkovic, J., & Kiebler, M. A. (2020) · Physiological Reviews · doi:10.1152/physrev.00047.2019 · Cited by 111
Tuning Specific Translation in Cancer Metastasis and Synaptic Memory: Control at the MNK–eIF4E Axis
Bramham, C. R., Jensen, K. B., & Proud, C. G. (2016) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2016.07.008 · Cited by 104
Banerjee, A., Ifrim, M. F., Valdez‐Sinon, A. N., Raj, N., & Bassell, G. J. (2018) · Brain Research · doi:10.1016/j.brainres.2018.04.008 · Cited by 111
Self-citationRegulatory discrimination of mRNAs by FMRP controls mouse adult neural stem cell differentiation
Liu, B., Li, Y., Stackpole, E. E., Novak, A., Gao, Y., Zhao, L., Zhao, X., & Richter, J. D. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1809588115 · Cited by 103
Self-citationGuo, D., Peng, Y., Wang, L., Sun, X., Wang, X., Liang, C., Yang, X., Li, S., Xu, J., Ye, W.-C., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-019-0472-7 · Cited by 102
Chu, J.-F., Majumder, P., Chatterjee, B., Huang, S., & Shen, C.-K. J. (2018) · Cell Reports · doi:10.1016/j.celrep.2019.10.061 · Cited by 97
Santini, E., Huynh, T. N., Longo, F., Koo, S. Y., Mojica, E. S., D’Andrea, L., Bagni, C., & Klann, E. (2017) · Science Signaling · doi:10.1126/scisignal.aan0665 · Cited by 92
Self-citationMale-specific deficits in natural reward learning in a mouse model of neurodevelopmental disorders
Grissom, N. M., McKee, S. E., Schoch, H., Bowman, N., Havekes, R., O'Brien, W. T., Mahrt, E., Siegel, S., Commons, K., Portfors, C., et al. (2018) · Molecular Psychiatry · doi:10.1038/mp.2017.184 · Cited by 92
Shah, S., Molinaro, G., Liu, B., Wang, R., Huber, K. M., & Richter, J. D. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.02.076 · Cited by 95
Self-citationSpecies-conserved SYNGAP1 phenotypes associated with neurodevelopmental disorders
Kılınç, M., Creson, T. K., Rojas, C., Aceti, M., Ellegood, J., Vaissière, T., Lerch, J. P., & Rumbaugh, G. (2018) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2018.03.008 · Cited by 87
Dynamic FMR1 granule phase switch instructed by m6A modification contributes to maternal RNA decay
Zhang, G., Xu, Y., Wang, X., Zhu, Y., Wang, L., Zhang, W., Wang, Y., Gao, Y., Wu, X., Cheng, Y., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28547-7 · Cited by 94
Metformin for treatment of fragile X syndrome and other neurological disorders
Gantois, I., Popic, J., Khoutorsky, A., & Sonenberg, N. (2019) · Annual Review of Medicine · doi:10.1146/annurev-med-081117-041238 · Cited by 87
Sawicka, K., Pyronneau, A., Chao, M., Bennett, M. V. L., & Zukin, R. S. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1610812113 · Cited by 84
Ghosh, A., Mizuno, K., Tiwari, S. S., Proitsi, P., Gomez Perez-Nievas, B., Glennon, E., Martinez-Nunez, R. T., & Giese, K. P. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-00882-7 · Cited by 78
Recent advances in gene therapy for neurodevelopmental disorders with epilepsy
Turner, T. J., Zourray, C., Schorge, S., & Lignani, G. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15168 · Cited by 71
Protein synthesis levels are increased in a subset of individuals with fragile X syndrome
Jacquemont, S., Pacini, L., Jønch, A. E., Cencelli, G., Rozenberg, I., He, Y., D’Andrea, L., Pedini, G., Eldeeb, M., Willemsen, R., et al. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy099 · Cited by 73
Identification of FMR1-regulated molecular networks in human neurodevelopmentPreprint
Li, M., Shin, J., Risgaard, R. D., Parries, M., Wang, J., Chasman, D. A., Liu, S., Roy, S., Bhattacharyya, A., & Zhao, X. (2020) · Genome Research · doi:10.1101/gr.251405.119 · Cited by 72
RNA Modifications and RNA Metabolism in Neurological Disease Pathogenesis
Chatterjee, B., Shen, C.-K. J., & Majumder, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111870 · Cited by 68
Nomura, T., Musial, T. F., Marshall, J. J., Zhu, Y., Remmers, C. L., Xu, J., Nicholson, D. A., & Contractor, A. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.2893-16.2017 · Cited by 64
Rodrigues, D. C., Mufteev, M., Weatheritt, R. J., Djuric, U., Ha, K., Ross, P. J., Wei, W., Piekna, A., Sartori, M. A., Byres, L., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2020.02.107 · Cited by 72
Booker, S. A., de Oliveira, L. S., Anstey, N. J., Kozić, Z., Dando, O., Jackson, A. D., Baxter, P. S., Isom, L. L., Sherman, D. L., Hardingham, G. E., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107988 · Cited by 61
Stoppel, L. J., Auerbach, B. D., Senter, R. K., Preza, A. R., Lefkowitz, R. J., & Bear, M. F. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.02.075 · Cited by 67
FUS-ALS mutants alter FMRP phase separation equilibrium and impair protein translation
Birsa, N., Ule, A. M., Garone, M. G., Tsang, B., Mattedi, F., Chong, P. A., Humphrey, J., Jarvis, S., Pisiren, M., Wilkins, O. G., et al. (2021) · Science Advances · doi:10.1126/sciadv.abf8660 · Cited by 67
Sunamura, N., Iwashita, S., Enomoto, K., Kadoshima, T., & Isono, F. (2018) · Scientific Reports · doi:10.1038/s41598-018-30025-4 · Cited by 62
Loss of the fragile X syndrome protein FMRP results in misregulation of nonsense-mediated mRNA decay
Kurosaki, T., Imamachi, N., Pröschel, C., Mitsutomi, S., Nagao, R., Akimitsu, N., & Maquat, L. E. (2021) · Nature Cell Biology · doi:10.1038/s41556-020-00618-1 · Cited by 60
FMRP links optimal codons to mRNA stability in neurons
Shu, H., Donnard, E. R., Liu, B., Jung, S., Wang, R., & Richter, J. D. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2009161117 · Cited by 60
Self-citationMcCamphill, P. K., Stoppel, L. J., Senter, R. K., Lewis, M. C., Heynen, A. J., Stoppel, D. C., Sridhar, V., Collins, K. A., Shi, X., Pan, J. Q., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aam8572 · Cited by 60
LIM-Kinases in Synaptic Plasticity, Memory, and Brain Diseases
Zablah, Y. B., Zhang, H., Gugustea, R., & Jia, Z. (2021) · Cells · doi:10.3390/cells10082079 · Cited by 58
The translational regulator FMRP controls lipid and glucose metabolism in mice and humans
Leboucher, A., Pisani, D. F., Martinez-Gili, L., Chilloux, J., Bermudez-Martin, P., Van Dijck, A., Ganief, T., Macek, B., Becker, J. A. J., Le Merrer, J., et al. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.01.002 · Cited by 56
Novel fragile X syndrome 2D and 3D brain models based on human isogenic FMRP-KO iPSCs.
Brighi, C., Salaris, F., Soloperto, A., Cordella, F., Ghirga, S., de Turris, V., Rosito, M., Porceddu, P. F., D’Antoni, C., Reggiani, A., et al. (2021) · Cell Death & Disease · doi:10.1038/s41419-021-03776-8 · Cited by 56
Excess ribosomal protein production unbalances translation in a model of Fragile X Syndrome
Seo, S. S., Louros, S. R., Anstey, N. J., Gonzalez‐Lozano, M. A., Harper, C. B., Verity, N., Dando, O., Thomson, S. R., Darnell, J. C., Kind, P. C., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30979-0 · Cited by 54
Achuta, V. S., Möykkynen, T. P., Peteri, U., Turconi, G., Rivera, C., KEINÄNEN, K. P., & Castrén, M. L. (2018) · Science Signaling · doi:10.1126/scisignal.aan8784 · Cited by 52
Raj, N., McEachin, Z. T., Harousseau, W., Zhou, Y., Zhang, F., Merritt-Garza, M. E., Taliaferro, J. M., Kalinowska, M., Marro, S. G., Hales, C. M., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.108991 · Cited by 54
Self-citationRegulation of RNA granules by FMRP and implications for neurological diseases
Lai, A., Valdez‐Sinon, A. N., & Bassell, G. J. (2020) · Traffic · doi:10.1111/tra.12733 · Cited by 57
Self-citationBhattacharya, A., Mamcarz, M., Mullins, C., Choudhury, A., Boyle, R. G., Smith, D. G., Walker, D. W., & Klann, E. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2015.369 · Cited by 51
Self-citationWeldon, M., Kılınç, M., Holder, J. L., & Rumbaugh, G. (2018) · Journal of Neurodevelopmental Disorders · doi:10.1186/s11689-018-9225-1 · Cited by 53
Filippini, A., Bonini, D., Lacoux, C., Pacini, L., Zingariello, M., Sancillo, L., Bosisio, D., Salvi, V., Mingardi, J., Via, L. L., et al. (2017) · RNA Biology · doi:10.1080/15476286.2017.1338232 · Cited by 56
Reducing histone acetylation rescues cognitive deficits in a mouse model of Fragile X syndrome
Li, Y., Stockton, M. E., Eisinger, B. E., Zhao, L., Miller, J. L., Bhuiyan, I., Gao, Y., Wu, Z., Peng, J., & Zhao, X. (2018) · Nature Communications · doi:10.1038/s41467-018-04869-3 · Cited by 50
Treating a novel plasticity defect rescues episodic memory in Fragile X model mice
Wang, W., Cox, B. M., Jia, Y., Le, A. A., Cox, C. D., Jung, K., Hou, B., Piomelli, D., Gall, C. M., & LYNCH, G. S. (2017) · Molecular Psychiatry · doi:10.1038/mp.2017.221 · Cited by 45
Kashima, R., Redmond, P. L., Ghatpande, P., Roy, S., Kornberg, T. B., Hanke, T., Knapp, S., Lagna, G., & Hata, A. (2017) · Science Signaling · doi:10.1126/scisignal.aai8133 · Cited by 46
Novel FMRP interaction networks linked to cellular stress
Taha, M. S., Haghighi, F., Stefanski, A., Nakhaei‐Rad, S., Jasemi, N. S. K., Kabbani, M. A. A., Görg, B., Fujii, M., Lang, P. A., Häussinger, D., et al. (2020) · FEBS Journal · doi:10.1111/febs.15443 · Cited by 51
Fragile X-related protein family: a double-edged sword in neurodevelopmental disorders and cancer
Majumder, M., Johnson, R. H., & Palanisamy, V. (2020) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2020.1810621 · Cited by 50
Chen, Y., Chang, Y., & Huang, Y. (2018) · Developmental Neurobiology · doi:10.1002/dneu.22653 · Cited by 42
Antisense Oligonucleotides Reduce RNA Foci in Spinocerebellar Ataxia 36 Patient iPSCs
Matsuzono, K., Imamura, K., Murakami, N., Tsukita, K., Yamamoto, T., Izumi, Y., Kaji, R., Ohta, Y., Yamashita, T., Abe, K., et al. (2017) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2017.06.017 · Cited by 44
The epitranscriptome in stem cell biology and neural development
Vissers, C. B., Sinha, A., Ming, G., & Song, H. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105139 · Cited by 44
Mechanisms regulating dendritic arbor patterning
Ledda, F., & Paratcha, G. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2588-8 · Cited by 43
Moissoglu, K., Yasuda, K., Wang, T., Chrisafis, G., & Mili, S. (2019) · eLife · doi:10.7554/elife.44752 · Cited by 43
mGluR5 Negative Modulators for Fragile X: Treatment Resistance and Persistence
Stoppel, D. C., McCamphill, P. K., Senter, R. K., Heynen, A. J., & Bear, M. F. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.718953 · Cited by 42
Bhat, S. A., Henry, R. J., Blanchard, A. C., Stoica, B. A., Loane, D. J., & Faden, A. I. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.14954 · Cited by 42
Chmielewska, J. J., Kuźniewska, B., Miłek, J., Urbanska, K., & Dziembowska, M. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1243-1 · Cited by 46
Homeostatic regulation of neuronal function: importance of degeneracy and pleiotropy
Yang, J., & Prescott, S. A. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1184563 · Cited by 40
Kenkel, W. M., Yee, J. R., Moore, K., Madularu, D., Kulkarni, P., Gamber, K., Nedelman, M., & Ferris, C. F. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.15 · Cited by 39
Rha, J., Jones, S. K., Fidler, J. A., Banerjee, A., Leung, S. W., Morris, K. J., Wong, J. C., Inglis, G. A. S., Shapiro, L. E., Deng, Q., et al. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx248 · Cited by 37
Self-citationRapid, experience-dependent translation of neurogranin enables memory encoding
Jones, K. J., Templet, S., Zemoura, K., Kuźniewska, B., Pena, F. X., Hwang, H., Ding, L. J., Haensgen, H., Nguyen, S. J., Saenz, C., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1716750115 · Cited by 41
Kalinowska, M., van der Lei, M. B., Kitiashvili, M., Mamcarz, M., Oliveira, M. M., Longo, F., & Klann, E. (2021) · Molecular Autism · doi:10.1186/s13229-022-00509-2 · Cited by 39
Self-citationAdaptive control of synaptic plasticity integrates micro- and macroscopic network function
Scott, D. N., & Frank, M. J. (2022) · Neuropsychopharmacology · doi:10.1038/s41386-022-01374-6 · Cited by 40
Enzyme Complexes Important for the Glutamate–Glutamine Cycle
McKenna, M. C., & Ferreira, G. C. (2016) · Advances in neurobiology · doi:10.1007/978-3-319-45096-4_4 · Cited by 35
Groß, C., Banerjee, A., Tiwari, D., Longo, F., White, A. R., Allen, A. G., Schroeder, L. M., Krzeski, J. C., Elsayed, N. A., Puckett, R. E., et al. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0150-5 · Cited by 38
Self-citationImplications of mRNA translation dysregulation for neurological disorders
Jishi, A., Qi, X., & Miranda, H. C. (2020) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2020.09.005 · Cited by 40
Donlin-Asp, P., Rossoll, W., & Bassell, G. J. (2017) · FEBS Letters · doi:10.1002/1873-3468.12621 · Cited by 38
Self-citationScotton, E., Antqueviezc, B., Vasconcelos, M., Dalpiaz, G., Géa, L. P., Goularte, J. F., Colombo, R., & Rosa, A. R. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.114963 · Cited by 37
Zajicek, A. S., Ruan, H., Dai, H., Skolfield, M. C., Phillips, H. L., Burnette, W. J., Javidfar, B., Sun, S., Akbarian, S., & Yao, W. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01571-1 · Cited by 36
Huang, Y., Méndez, R., Fernández, M., & Richter, J. D. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02088-x · Cited by 36
Self-citationFMRP Interacts with C/D Box snoRNA in the Nucleus and Regulates Ribosomal RNA Methylation
D’Souza, M. N., Gowda, N. K. C., Tiwari, V., Babu, R. O., Anand, P., Dastidar, S. G., Singh, R., James, O. G., Selvaraj, B. T., Pal, R., et al. (2018) · iScience · doi:10.1016/j.isci.2018.11.007 · Cited by 34
FMRP modulates the Wnt signalling pathway in glioblastoma
Pedini, G., Buccarelli, M., Bianchi, F., Pacini, L., Cencelli, G., D’Alessandris, Q. G., Martini, M., Giannetti, S., Sasso, F., Melocchi, V., et al. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05019-w · Cited by 33
Bienkowski, R. S., Banerjee, A., Rounds, J. C., Rha, J., Omotade, O. F., Groß, C., Morris, K. J., Leung, S. W., Pak, C., Jones, S. K., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.07.038 · Cited by 32
Self-citationPilaz, L., & Silver, D. L. (2017) · FEBS Letters · doi:10.1002/1873-3468.12626 · Cited by 31
Utami, K. H., Yusof, N. A. B. M., Kwa, J. E., Peteri, U., Castrén, M. L., & Pouladi, M. A. (2020) · Molecular Autism · doi:10.1186/s13229-020-00350-5 · Cited by 34
Huang, L., Wang, J., Liang, G., Gao, Y., Jin, S., Hu, J., Yang, X., Lao, J., Chen, J., Luo, Z.-C., et al. (2021) · Theranostics · doi:10.7150/thno.60531 · Cited by 32
Excessive proteostasis contributes to pathology in fragile X syndrome
Louros, S. R., Seo, S. S., Maio, B., Martinez‐Gonzalez, C., Gonzalez‐Lozano, M. A., Muscas, M., Verity, N. C., Wills, J. C., Li, K. W., Nolan, M. F., et al. (2022) · Neuron · doi:10.1016/j.neuron.2022.11.012 · Cited by 32
Astrocytes mediate cell non-autonomous correction of aberrant firing in human FXS neurons.
Sharma, S. D., Reddy, B. K., Pal, R., Ritakari, T. E., Cooper, J. D., Selvaraj, B. T., Kind, P. C., Chandran, S., Wyllie, D. J. A., & Chattarji, S. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112344 · Cited by 31
FMRP regulates presynaptic localization of neuronal voltage gated calcium channels
Ferron, L., Novazzi, C. G., Pilch, K. S., Moreno, C., Ramgoolam, K., & DOLPHIN, A. C. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104779 · Cited by 31
Salcedo‐Arellano, M. J., Cabal-Herrera, A. M., Punatar, R., Clark, C. J., Romney, C. A., & Hagerman, R. J. (2020) · Neurotherapeutics · doi:10.1007/s13311-020-00968-6 · Cited by 32
Altered expression of the FMR1 splicing variants landscape in premutation carriers
Tseng, E., Tang, H.-T., AlOlaby, R. R., Hickey, L., & Tassone, F. (2017) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2017.08.007 · Cited by 33
Metadata
- Authors
- Richter, J. D., Bassell, G. J., & Klann, E.
- Affiliations
- University of Massachusetts Chan Medical School (US)
- Emory University (US)
- New York University (US)
- Corresponding author
- Klann, Eric
- Venue
- Nature Reviews Neuroscience
- Published
- 2015-09-09
- Volume
- 16
- Issue
- 10
- Pages
- 595-605
- ISSN
- 1471-003X (ISSN-L)
- 1471-0048
- PMC
- PMC4688896
- OpenAlex
- W2237226910
- Cited by
- 275
- References
- 127
- Citations by year
- 2026: 14 · 2025: 21 · 2024: 9 · 2023: 25 · 2022: 32 · 2021: 24 · 2020: 36 · 2019: 24 · 2018: 35 · 2017: 33 · 2016: 20 · 2015: 1
- FWCI
- 3.83
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of Neurological Disorders and Stroke (R01NS079415, R01NS047384)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (U54HD082013, HD082013)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA and protein synthesis mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- fragile X syndrome, FMRP, mRNA translation, RNA-binding proteins, intellectual disability, autism spectrum disorder, pharmacological rescue, genetic rescue, synaptic function, neuronal morphology, translational regulation
- MeSH terms
- Animals, Fragile X Syndrome, Homeostasis, Humans, RNA, Messenger, Gene Expression, Mice, Fragile X Messenger Ribonucleoprotein 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review